Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Cifuentes

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
ACS Applied Materials & Interfaces|January 13, 2025
Triple-Negative Breast Cancer Aptamer-Targeting Porous Silicon NanocarrierAnkit Malhotra, Pouya Dehghankelishadi, Ishdeep Kaur, et al.
Biomaterials|February 29, 2020
Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasisMarietta Landgraf, Christoph A Lahr, Ishdeep Kaur, et al.
Pharmaceutics|May 27, 2023
Combination of Chemotherapy and Mild Hyperthermia Using Targeted Nanoparticles: A Potential Treatment Modality for Breast CancerIshdeep Kaur, Terence Tieu, Veerasikku G Deepagan, et al.
Journal of Extracellular Vesicles|June 24, 2023
First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healingJancy Johnson, Sam Q K Law, Mozhgan Shojaee, et al.
Cancer Research|February 6, 2021
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate CancerMargaret M Centenera, Julia S Scott, Jelle Machiels, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
ACS Applied Materials & Interfaces|January 13, 2025
Triple-Negative Breast Cancer Aptamer-Targeting Porous Silicon NanocarrierAnkit Malhotra, Pouya Dehghankelishadi, Ishdeep Kaur, et al.
Biomaterials|February 29, 2020
Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasisMarietta Landgraf, Christoph A Lahr, Ishdeep Kaur, et al.
Pharmaceutics|May 27, 2023
Combination of Chemotherapy and Mild Hyperthermia Using Targeted Nanoparticles: A Potential Treatment Modality for Breast CancerIshdeep Kaur, Terence Tieu, Veerasikku G Deepagan, et al.
Journal of Extracellular Vesicles|June 24, 2023
First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healingJancy Johnson, Sam Q K Law, Mozhgan Shojaee, et al.
Cancer Research|February 6, 2021
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate CancerMargaret M Centenera, Julia S Scott, Jelle Machiels, et al.
Pageof 3